These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8525883)

  • 21. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
    Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
    J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Adv Exp Med Biol; 1995; 371B():1495-500. PubMed ID: 7502844
    [No Abstract]   [Full Text] [Related]  

  • 25. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
    Glenn GM; Scharton-Kersten T; Vassell R; Mallett CP; Hale TL; Alving CR
    J Immunol; 1998 Oct; 161(7):3211-4. PubMed ID: 9759833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-sampled and air-dried cervicovaginal secretions can be used for analyses of mucosal antibodies.
    Hordnes K; Trovik J; Tynning T; Haneberg B
    J Immunol Methods; 1998 Nov; 220(1-2):151-9. PubMed ID: 9839936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genital-associated lymphoid tissue in female non-human primates.
    Lehner T; Panagiotidi C; Bergmeier LA; Tao L; Brookes R; Gearing A; Adams S
    Adv Exp Med Biol; 1995; 371A():357-65. PubMed ID: 8525944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral immunization induces local and distant mucosal immunity in swine.
    Hyland K; Foss DL; Johnson CR; Murtaugh MP
    Vet Immunol Immunopathol; 2004 Dec; 102(3):329-38. PubMed ID: 15507316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery.
    Russell MW; Wu HY; Hajishengallis G; Hollingshead SK; Michalek SM
    Adv Vet Med; 1999; 41():105-14. PubMed ID: 9890012
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulation of mucosal immunity.
    Lewis DJ; Hayward CM
    Methods Mol Med; 2003; 87():245-54. PubMed ID: 12958460
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
    Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
    Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin A: localization in rectal mucosal epithelial cells.
    Gelzayd EA; Kraft SC; Fitch FW
    Science; 1967 Aug; 157(3791):930-1. PubMed ID: 4951151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.
    Wassen L; Jertborn M
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):447-52. PubMed ID: 15753258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA deficiency in children. Immunoglobulin-containing cells in the intestinal mucosa, immunoglobulins in secretions and serum IgA levels.
    Savilahti E
    Clin Exp Immunol; 1973 Mar; 13(3):395-406. PubMed ID: 4633850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.
    Pierce NF; Cray WC
    J Immunol; 1982 Mar; 128(3):1311-5. PubMed ID: 6173431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
    Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
    J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholera and pertussis toxins, but not forskolin or LT-B, adjuvant IgA antibody responses to orally administered antigen.
    Wilson AD; Robinson A; Irons L; Stokes CR; Bland PW
    Adv Exp Med Biol; 1995; 371B():1523-6. PubMed ID: 7502849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.